Medication info

Megaglimet Tablet 1/250 mg

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Glimepiride›1mg / 1 tabletMetformin Hydrochloride›250mg / 1 tablet
Manufacturer / importer
LNC Bio Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 202000589 · Approved 2020.02.04

This product's status changed to Approval withdrawn on 2024.07.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this drug 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted based on the patient's current medications and blood glucose levels. In clinical studies, the initial daily dose of this drug was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride as a single agent, there is generally little additional benefit at doses above 4mg per day; however, some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as an alternative to combination therapy, administer based on the dosage regimen of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next administration.

Ingredients

Manufacturer
LNC Bio Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Insulin-independent diabetes
View approved original text

This medication is used for patients with insulin-independent diabetes, namely type 2 diabetes. It is utilized when blood glucose control is insufficient with only glymepiride or metformin treatment, while also adhering to dietary and exercise regimens. Instead of combination therapy with glymepiride and metformin, this medication can be used. This helps improve blood glucose control effectiveness, aiding in diabetes management. It is a useful treatment for improving patients' blood glucose levels.

How to take

Adult dose

Administer this drug 1 to 2 times daily immediately before or with meals. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted based on the patient's current medications and blood glucose levels. In clinical studies, the initial daily dose of this drug was glimepiride/metformin hydrochloride 2mg/500mg, and it was gradually increased based on blood glucose monitoring results, up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride as a single agent, there is generally little additional benefit at doses above 4mg per day; however, some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as an alternative to combination therapy, administer based on the dosage regimen of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than one dose at the next administration.

Precautions

This medication may cause severe lactic acidosis or hypoglycemia; therefore, it should be temporarily discontinued and a doctor consulted in the event of rapidly declining kidney function or dehydration symptoms. It should not be used in patients with impaired kidney function or severe liver dysfunction, pregnant or breastfeeding women, or patients with acute metabolic acidosis. In the initial stages of treatment, the risk of hypoglycemia is high, so patients with irregular meal patterns, poor nutritional status, excessive exercise, or alcohol consumption should be particularly cautious. This medication may cause gastrointestinal disturbances (diarrhea, nausea, vomiting, etc.), which are usually temporary; however, if severe symptoms occur, discontinuation may be necessary. Allergic reactions or skin rashes, as well as abnormal blood symptoms may occur; if any unusual symptoms arise, the doctor should be informed immediately. Regular monitoring of kidney function, blood glucose, and hematological tests are required. Monitoring for potential vitamin B12 deficiency is also necessary. There may be interactions when taken with other medications, so inform the healthcare professional of any medicines being taken. Pregnant women or those planning to become pregnant should not take this medication, and breastfeeding women should consult with a doctor. In cases of overdose, severe hypoglycemia or lactic acidosis may occur, so the prescribed dosage must be adhered to, and immediate medical attention should be sought if any unusual symptoms arise. Caution is needed while driving or operating machinery due to the risk of accidents from hypoglycemia or dizziness. The safety and efficacy of this medication have not been established in children, so caution is advised when using it.

Side effects

  • Lactate acidosis
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal bloating
  • loss of appetite
  • indigestion
  • constipation
  • abdominal pain
Show 77 more
  • metallic taste
  • visual impairment
  • erythema
  • itching
  • urticaria
  • rash
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • anemia
  • granulocytopenia
  • agranulocytosis
  • pancytopenia
  • macrocytic anemia
  • increased liver enzymes
  • liver function impairment
  • cholestasis
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photosensitivity
  • decreased serum sodium concentration
  • abdominal pain
  • abdominal bloating
  • vomiting
  • indigestion
  • palpitations
  • dizziness
  • diarrhea
  • nausea
  • leg edema
  • cardiac arrest
  • rectal carcinoma
  • vertigo
  • liver dysfunction
  • arthralgia
  • facial swelling
  • erectile dysfunction
  • hair loss
  • flushing
  • gastritis
  • headache
  • severe hunger
  • fatigue
  • sleep
  • weakness
  • drowsiness
  • sleep disorders
  • instability
  • aggression
  • attention deficit
  • inability to pay attention
  • abnormal reactions
  • depression
  • confusion
  • language disorders
  • aphasia
  • visual disturbances
  • tremors
  • paralysis
  • sensory disorders
  • dizziness
  • inability to self-regulate
  • delirium
  • cerebral seizures
  • loss of consciousness
  • coma
  • weak respiration
  • slow pulse
  • sweating
  • moist skin
  • anxiety
  • rapid pulse
  • hypertension
  • palpitations
  • angina
  • deep venous thrombosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture exposure. It is also recommended to keep it at room temperature between 1 degree and 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness for an extended period.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.